Earnings and loans up at Citizens Business Bank
CVB Financial Corp., the parent company of Citizens Business Bank, saw higher net income and loan growth, excluding Paycheck Protection Plan loans, in its second quarter. The Ontario-based bank, which has four branches in Ventura County and one in Santa Barbara, reported $51.2 million in net income for the quarter ended June 30, or 47 Read More →
American Riviera Bank reports strong second quarter
American Riviera Bank more than doubled its net income from the second quarter of 2020 to the same quarter of 2021, buoyed by Paycheck Protection Program fee income. The Santa Barbara-based bank reported $3.57 million in net income in the most recent quarter, or 70 cents per share, compared to $1.57 million, or 31 cents Read More →
Pacific Western Bank earnings more than quintuple in Q2
PacWest Bancorp’s net income shot up more than 440% year-over-year as it saw strong loan growth and core deposit growth. The Los Angeles-based parent company of Pacific Western Bank, which has 15 branches in the tri-county region, recorded net earnings of $180.5 million, or $1.52 per diluted share, in the second quarter of 2021. In Read More →
Bank of the Sierra reports record earnings
Sierra Bancorp reported record earnings boosted by lower loan and lease losses and improvements to the overall economy, the bank announced July 19. The parent company of Bank of the Sierra said it had $11.7 million in net income for the quarter ended June 30, or 76 cents per diluted share, compared to $8.3 million Read More →
Teledyne secures Navy contract worth up to $39M
Thousand Oaks-based Teledyne Technologies announced July 19 that its subsidiary, Teledyne Brown Engineering, was awarded a U.S. Navy contract for underwater drones worth as much as $39.2 million. The contract has a maximum base value of $27.4 million over five years, with five one-year option periods and a maximum value of $39.2 million if all Read More →
Losses mount at Resonant, but CEO predicts big things as 5G future approaches
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA accuses Amgen of misleading advertising
The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →
